Sally C. Medley

Array ( [id] => 3546375 [patent_doc_number] => 05547669 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-20 [patent_title] => 'Recombinant peptides comprising T cell epitopes of the cat allergen, Fel d I' [patent_app_type] => 1 [patent_app_number] => 7/807529 [patent_app_country] => US [patent_app_date] => 1991-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 19066 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/547/05547669.pdf [firstpage_image] =>[orig_patent_app_number] => 807529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3010172 [patent_doc_number] => 05308626 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-05-03 [patent_title] => 'Lymphokine activated effector cells for antibody-dependent cellular cytotoxicity (ADCC) treatment of cancer and other diseases' [patent_app_type] => 1 [patent_app_number] => 7/808958 [patent_app_country] => US [patent_app_date] => 1991-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11369 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/308/05308626.pdf [firstpage_image] =>[orig_patent_app_number] => 808958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3455740 [patent_doc_number] => 05401651 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-03-28 [patent_title] => 'DNA encoding ENA-78, a neutrophil activating factor' [patent_app_type] => 1 [patent_app_number] => 7/778413 [patent_app_country] => US [patent_app_date] => 1991-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 20 [patent_no_of_words] => 7748 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/401/05401651.pdf [firstpage_image] =>[orig_patent_app_number] => 778413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3440128 [patent_doc_number] => 05429921 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-07-04 [patent_title] => 'Assays for agonists and antagonists of recombinant human calcium channels' [patent_app_type] => 1 [patent_app_number] => 7/745206 [patent_app_country] => US [patent_app_date] => 1991-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 23 [patent_no_of_words] => 30566 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/429/05429921.pdf [firstpage_image] =>[orig_patent_app_number] => 745206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2934286 [patent_doc_number] => 05219997 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-15 [patent_title] => 'Monoclonal antibody which inhibits the adhesion functions of the .beta. integrin, CR3' [patent_app_type] => 1 [patent_app_number] => 7/703941 [patent_app_country] => US [patent_app_date] => 1991-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2342 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/219/05219997.pdf [firstpage_image] =>[orig_patent_app_number] => 703941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3035018 [patent_doc_number] => 05328991 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-07-12 [patent_title] => 'Preparation of alkali-modified cat dander allergen (Fel d I) for immunotherapeutic purposes' [patent_app_type] => 1 [patent_app_number] => 7/662193 [patent_app_country] => US [patent_app_date] => 1991-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5854 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/328/05328991.pdf [firstpage_image] =>[orig_patent_app_number] => 662193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3073467 [patent_doc_number] => 05322699 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-06-21 [patent_title] => 'Leukocyte-derived CR3 modulator, integrin modulating factor-1 (IMF-1)' [patent_app_type] => 1 [patent_app_number] => 7/650062 [patent_app_country] => US [patent_app_date] => 1991-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 15286 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/322/05322699.pdf [firstpage_image] =>[orig_patent_app_number] => 650062 [rel_patent_id] =>[rel_patent_doc_number] =>)